Member Info for mazik

Huge market Cannabis backed medicineis legalised in Canada and California...well we priced at prime multi bagger at its prime GLA

Marineville thanks , lets see what Nigel will bring for us long termer hoping and waiting its the name of the game :-) Sorry for investor's who piled in yesterday especially fellow investor Scott...and the 150k buy late yesterday...GLA

A must watch for Marineville.....hah! hah!

Thanks Marineville for your understanding, here we just have to wait its studies result and our investment was £50k well we want good results to move forward GLA its not over..IMO

Marineville give us a break, all this your doom and gloom opinion...go back to your cave . You are renowned for scraping at the bottom of the barrel to make your profit's disregarding fellow investor's... have time for investor who have lost all at Deb and its a setback here.....

Well long road as I said yesterday, now I hope this guy can give some good news in the coming weeks GLA

Join the party long way to go

The licence agreement with China Medical Systems, a leading Hong Kong based Chinese pharmaceutical company. This is a key collaboration for Midatech that provides a strong endorsement of our technologies and pipeline whilst establishing a solid foundation for a successful and ambitious long-term partnership. The agreement will enable development of current and new products and extend our reach to the important markets of China and South East Asia.

Well could not resist but to top up another 52k at this give away price during rerating..GLA expect to be mid double figures next week

Ratified by the Spanish Government backed by Chinese multi Billionaire already plans on the verge of production now its will be rerated as expected towards multiple of todays Capitalisation...IMO

Very positive we will be moving north until FDA meeting

Well how can they be allowed to run this game seems we all have lost except these shaista's all tried to to run any business...they cannot even arrange to run a booze party because they will be drunk before it starts, well i have lost over 4k and left this party 2 weeks due to effecting my health and doing my head on conversions...Hope all of u recover as I have written off ...looking at their bio data or their CV I should have been warned.

Positive buying now

It will pop up as many buyers getting in..imo

More confetti's, well done holders its better to invest in for charity at least u will have the blessing of Lord :-)

News is due looks like an RNS is on its way IMO, if we receive approval GOG we will head for multiple of today's price IMO

Two years ago multifold and now with dilutions but cash rich we should be rerated accordingly IMO, It will be interesting to know the brokers note at present :-)

Goodbye traders this will be rerated once the weak ones offload for peanuts..imo. Once the institutions start coming on board we will be off double digit IMO

The proceeds are all there for exciting 6 months In order for Nuvec® to be ready to enter clinical studies with any partner molecule, it must be capable of being provided at the required scale and under GMP manufacturing conditions. The Directors believe it is prudent to develop Nuvec® towards this level of readiness to provide comfort to potential collaboration partners. This work will focus on: improving the particle resuspendability; investigating formulation stability with research DNA; transferring the manufacturing process to a GMP capable partner; and ensuring N4 Pharma can make the required quantum at that partners facility. Subject to achieving this, the technology transfer would be expected to start in Q3 2019. GLA the recent placing and RNS gives us hope for quantum leap IMO

Midatech will manufacture and supply the licensed products, earning a manufacturing margin “in the low double-digit percentage range”, although the margin will be a bit less for MTX110 – a treatment for a rare type of brain tumour found in children – as Novartis will take a slice for the use of its panbinostat.
On top of that, the AIM firm is also entitled to receive various regulatory and sales-based milestone payments for each product which could run into the tens of millions, although these are not expected for a couple of years yet.
“The board believes that this partnership with the licensees has the potential to accelerate the development of the company's assets in the CMS Territory with a high quality, expert partner with demonstrable development and significant sales expertise, whilst permitting the company to retain its focus on its main target markets in the US and the EU and potentially to service the rest of the world.”